Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats-Reference-Cited by-同舟云学术

Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats

Published:2010-10-06 Issue:4 Volume:25 Page:469-478
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

Bancila M.,Copin J.-C.,Daali Y.,Schatlo B.,Gasche Y.,Bijlenga Philippe

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2010.00879.x/fullpdf

Reference30 articles.

1. Survival of 1476 patients initially resuscitated from out of hospital cardiac arrest;Cobbe;BMJ,1996

2. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation;Bunch;N. Engl. J. Med.,2003

3. Cardiac resuscitation;Eisenberg;N. Engl. J. Med.,2001

4. Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model;Valenzuela;Circulation,1997

5. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study;Kleindorfer;Stroke,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ML218 modulates calcium binding protein, oxidative stress, and inflammation during ischemia-reperfusion brain injury in mice;European Journal of Pharmacology;2024-11

2. Cav3.2 channel regulates cerebral ischemia/reperfusion injury: a promising target for intervention;Neural Regeneration Research;2023-12-15

3. T‐type calcium channels as therapeutic targets in essential tremor and Parkinson's disease;Annals of Clinical and Translational Neurology;2023-02-04

4. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review;Journal of Controlled Release;2021-12

5. In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches;Medicinal Research Reviews;2020-08-20